Clinical response to a lapatinib-based therapy for a Li-Fraumeni Syndrome patient with a novel HER2V659E mutation

1. Serra, V.
2. Vivancos, A.
3. Puente, X.S.
4. Felip, E.
5. Silberschmidt, D.
6. Caratù, G.
7. Parra, J.-L.
8. De Mattos-Arruda, L.
9. Grueso, J.
10. Hernández-Losa, J.
11. Arribas, J.
12. Prudkin, L.
13. Nuciforo, P.
14. Scaltriti, M.
15. Seoane, J.
16. Baselga, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1158/2159-8290.CD-13-0132 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus